Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3420286, 15 pages
https://doi.org/10.1155/2017/3420286
Research Article

Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH

1Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany
2Department of Anatomy and Cell Biology, University Hospital RWTH Aachen, Aachen, Germany
3Department of Pharmacology & Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
4Department of Immunology, Complutense University School of Medicine, Madrid, Spain
512 de Octubre Health Research Institute (imas12), Madrid, Spain

Correspondence should be addressed to Daniela C. Kroy; ed.nehcaaku@yorkd

Received 12 December 2016; Accepted 22 March 2017; Published 6 June 2017

Academic Editor: M. Yvonne Alexander

Copyright © 2017 Pierluigi Ramadori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Arechederra, R. Carmona, M. Gonzales-Nunez et al., “Met signaling in cardiomyocytes is required for normal cardiac function in adult mice,” Biochimica et Biophysica Acta, vol. 1832, no. 12, pp. 2204–2215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Niimura, N. Takagi, K. Takagi et al., “Prevention of apoptosis-inducing factor translocation is a possible mechanism for protective effects of hepatocyte growth factor against neuronal cell death in the hippocampus after transient forebrain ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 11, pp. 1354–1365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Ferraro, S. Corso, E. Fasano et al., “Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS),” Oncogene, vol. 25, no. 26, pp. 3689–3698, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Jagadeeswaran, S. Jagadeeswaran, V. P. Bindokas, and R. Salgia, “Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 292, no. 6, pp. L1488–L1494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. C. Kroy, F. Schumacher, P. Ramadori et al., “Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice,” Journal of Hepatology, vol. 61, no. 4, pp. 883–890, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. L. E. Gomez-Quiroz, D. Seo, and Y. H. Lee, “Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress,” Toxicology, vol. 361-362, pp. 39–48, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Suzuki and M. Yamamoto, “Molecular basis of the Keap1-Nrf2 system,” Free Radical Biology & Medicine, vol. 88, Part B, pp. 93–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Al-Sawaf, T. Clarner, A. Fragoulis et al., “Nrf2 in health and disease: current and future clinical implications,” Clinical Science (London, England), vol. 129, no. 12, pp. 989–999, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Ramadori, H. Drescher, S. Erschfeld et al., “Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development,” Free Radical Biology & Medicine, vol. 91, pp. 114–126, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Okawa, H. Motohashi, A. Kobayashi, H. Aburatani, T. W. Kensler, and M. Yamamoto, “Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity,” Biochemical and Biophysical Research Communications, vol. 339, no. 1, pp. 79–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kaldenbach, A. Giebeler, D. F. Tschaharganeh et al., “Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes,” Gut, vol. 61, no. 8, pp. 1209–1218, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Berres, R. R. Koenen, A. Rueland et al., “Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice,” The Journal of Clinical Investigation, vol. 120, no. 11, pp. 4129–4440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Abelmegeed, A. Banerjee, S. H. Yoo, S. Jang, F. J. Gonzalez, and B. J. Song, “Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis,” Journal of Hepatology, vol. 57, no. 4, pp. 860–866, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. I. A. Leclercq, G. C. Farrell, J. Field, D. R. Bell, F. J. Gonzalez, and G. R. Robertson, “CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis,” The Journal of Clinical Investigation, vol. 105, no. 8, pp. 1067–1075, 2000. View at Publisher · View at Google Scholar
  15. I. García-Ruiz, P. Solís-Muñoz, D. Fernández-Moreira, M. Grau, T. Muñoz-Yagüe, and J. A. Solís-Herruzo, “NADPH oxidase is implicated in the pathogenesis of oxidative phosphorylation dysfunction in mice fed a high-fat diet,” Scientific Reports, vol. 6, p. 23664, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Saphis, E. Delvin, J. M. Borys, and E. Levy, “Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis,” Antioxidants & Redox Signaling, vol. 26, no. 10, pp. 519–541, 2016. View at Publisher · View at Google Scholar
  17. H. Perazzo and J. Dufour, “The therapeutic landscape of non-alcoholic steatohepatitis,” Liver International, vol. 37, no. 5, pp. 634–647, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Musso, M. Cassader, and R. Gambino, “Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies,” Nature Reviews Drug Discovery, vol. 15, no. 4, pp. 249–274, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. S. S. Thorgeirsson, “The central role of the c-Met pathway in rebuilding the liver,” Gut, vol. 61, no. 8, pp. 1105-1106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L. E. Gomez-Quiroz, V. M. Factor, P. Kaposi-Novak, C. Coulouarn, E. A. Conner, and S. S. Thorgeirsson, “Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis,” The Journal of Biological Chemistry, vol. 283, no. 21, pp. 14581–14589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Enriquez-Cortina, M. Almonte-Becerril, D. Clavijo-Cornejo et al., “Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage,” Toxicological Sciences, vol. 135, no. 1, pp. 26–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Clavijo-Cornejo, C. Enriquez-Cortina, A. Lopez-Reyes et al., “Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes,” Biochimie, vol. 95, no. 6, pp. 1177–1184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Dominguez-Perez, N. Nuno-Lambarri, D. Clavijo-Cornejo et al., “Hepatocyte growth factor reduces free cholesterol-mediated lipotoxicity in primary hepatocytes by countering oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 7960386, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Y. Kay, W. D. Kim, S. J. Hwang et al., “Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding,” Antioxidants & Redox Signaling, vol. 15, no. 8, pp. 2135–2146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Dobrzyn, A. Dobrzyn, M. Miyazaki et al., “Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 17, pp. 6409–6414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. S. M. Jeon, N. S. Chandel, and N. Hay, “AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress,” Nature, vol. 485, no. 7400, pp. 661–665, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. B. Ahn, J. Y. Je, Y. S. Kim, S. J. Park, and B. I. Kim, “Induction of Nrf2-mediated phase II detoxifying/antioxidant enzymes in vitro by chitosan-caffeic acid against hydrogen peroxide-induced hepatotoxicity through JNK/ERK pathway,” Molecular and Cellular Biochemistry, vol. 424, no. 1-2, pp. 79–86, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Pulli, M. Ali, Y. Iwamoto et al., “Myeloperoxidase-hepatocyte-stellate cell cross talk promotes hepatocyte injury and fibrosis in experimental nonalcoholic steatohepatitis,” Antioxidants & Redox Signaling, vol. 23, no. 16, pp. 1255–1269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Ma, A. H. Kesarvala, T. Eggert et al., “NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis,” Nature, vol. 531, no. 7593, pp. 253–257, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Giebeler, M. V. Boekschoten, C. Klein et al., “c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice,” Gastroenterology, vol. 137, no. 1, pp. 297–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. N. J. Torok, “Dysregulation of redox pathways in liver fibrosis,” American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 311, no. 4, pp. G667–G674, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Ramadori, H. Drescher, S. Eschfeld et al., “Hepatic Nrf2 overexpression inhibits the deleterious effects induced by c-met deficiency in the progression of NASH,” Zeitschrift für Gastroenterologie, vol. 54, no. 12, pp. 1343–1404, 2016. View at Google Scholar